ArticleHaematologica2021

Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma.

Matteo Costacurta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.